Pro Medicus Limited (ASX:PME)

Market Cap	12.14B -58.4%
Revenue (ttm)	240.57M +30.3%
Net Income	234.70M +138.8%
EPS	2.24 +138.7%
Shares Out	104.47M
PE Ratio	51.83
Forward PE	67.60
Dividend	0.64 (0.59%)
Ex-Dividend Date	Feb 26, 2026

Volume	795,477
Average Volume	587,028
Open	120.10
Previous Close	115.91
Day's Range	120.10 - 127.67
52-Week Range	107.75 - 336.00
Beta	0.60
RSI	37.82
Earnings Date	Feb 12, 2026

About Pro Medicus

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and commu...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1983
• Employees: 132
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PME

Financial Performance

In fiscal year 2025, Pro Medicus's revenue was 212.98 million, an increase of 31.88% compared to the previous year's 161.50 million. Earnings were 115.22 million, an increase of 39.16%.